Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Income from licenses are twice as high as previously estimated

Income from licenses are twice as high as previously estimated

posted on Jun 12, 2008 09:28AM

When I calculated the average income and EPS for each license sold in the Dec-Feb Q my assumption was that there where 16 companies - based on the announcements during that Q. Now we know that the J’s are not on PTSC’s licensed list. So that takes the number down to 12 companies. We also now know, based on the recent Hawk Associates release, that revenue from 4 other companies that were announced in late February were not included in the Dec-Feb results. Income from those 4 companies will be in the upcoming Q report results. So that leaves only 8 companies in the Dec-Feb Q.

.

My averages of EPS and income per license thus doubled because there were only half my estimated licenses sold in that Q. We made 2 cents EPS on 8 companies, not on 16. That gives us .0025 cents per license.

.

Based on PTSC and Hawk Associates releases, we’ll see income from 8 companies in the Mar-May Q results. Using my refined averages we would expect to see 2 cents EPS in the next Q report (sometime in August). If that happens we’ll drop from 5 cents TTM EPS to 4 cents EPS. A very good TTM EPS in my mind, worthy of a 40 cent or more SP.

Share
New Message
Please login to post a reply